Bloomberg Law Publish Date: November 14, 2022 Read the Full Article >> More than half of women ages 15 to 49 who use a common arthritis drug risk losing access under restrictive state abortion laws, according to a new study based on nationwide health-care data. The analysis, published Saturday in the Arthritis & Rheumatology Journal, found[…]
HealthEconomics.com – A Scientist.com Company Publish Date: August 26th, 2022 Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds and protects the nerve fibers of the central nervous system. The result is a disabling disease that causes damage to the brain and spinal cord[…]
THU, JUN 9, 2022 11:00 AM – 12:00 PM EDT Register >> Assessing clinical and functional status in Multiple Sclerosis (MS) using the Expanded Disability Status Scale (EDSS) is critical to inform treatment decisions and monitoring the progression of illness. Yet, EDSS scores are documented infrequently and inconsistently due to the time required to complete[…]
Thu, Apr 21, 2022 11:00 AM – 12:00 PM EDT Register>> There has been substantial recent progress in new heart failure (HF) treatments, yet there is still a large unmet need in the treatment of HF with preserved, mid-range, and reduced ejection fraction as well those with co-morbidities. Linked real-world data (RWD) can provide a[…]
BioPharma Dive Online April 4, 2022 Read the Full Article >> The large quantity of digitized healthcare data in the U.S., combined with advancements in data collection and processing technologies, present an enormous opportunity to shift dramatically how post-marketing safety studies can and should be conducted. The Traditional Approach Post-marketing safety studies are a[…]
